Pancreatic Cancer Research

ResearcherUniversity of VeronaActive in the last 2 years

Stefano Francesco Crinò

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4560-8741; OpenAlex author ID A5007594153. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
36
Papers, trials and grants by year

2018: 1 paper · 2019: 2 papers · 2020: 1 paper · 2021: none · 2022: none · 2023: 2 papers · 2024: 1 paper · 2025: 2 papers

Papers 9

  1. Reducing the incidence of pancreatic cancer through radiofrequency ablation of mucinous cystic neoplasms: What is the evidence? Co-author DOI 10.1016/j.bpg.2025.101986↗
  2. Local ablation disrupts immune evasion in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2024.217327↗
  3. Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: The open-label, multicenter, phase II nITRO trial. Co-author DOI 10.1016/j.ejca.2023.113430↗
  4. Regret affects the choice between neoadjuvant therapy and upfront surgery for potentially resectable pancreatic cancer. Co-author DOI 10.1016/j.surg.2023.01.016↗
  5. A penetrating foreign body mimicking pancreatic cancer (with videos). Last author DOI 10.4103/eus-d-22-00070↗
  6. Pancreatico-gastric fistula mimicking malignant infiltration following transgastric EUS-FNA of resectable pancreatic ductal adenocarcinoma. First author DOI 10.4103/eus.eus_5_20↗
  7. EUS-guided radiofrequency ablation of the celiac axis in pancreatic cancer: Is money worth the pain? Last author DOI 10.1016/j.gie.2018.08.048↗
  8. Ablation treatments in unresectable pancreatic cancer. Co-author DOI 10.23736/s0026-4733.18.07881-1↗
  9. Palliative therapy in pancreatic cancer-interventional treatment with radiofrequency ablation/irreversible electroporation. Co-author DOI 10.21037/tgh.2018.10.05↗

Closest collaborators

The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mirko D’Onofrio · 4 shared papers, 2018–2025 · strength 0.49
  2. Claudio Bassi · 4 shared papers, 2018–2025 · strength 0.49
  3. Roberto Salvia · 4 shared papers, 2018–2025 · strength 0.49
  4. Giuseppe Malleo · 3 shared papers, 2020–2025 · strength 0.45
  5. Salvatore Paiella · 3 shared papers, 2018–2025 · strength 0.34
  6. Aldo Scarpa · 2 shared papers, 2024–2025 · strength 0.32
  7. Jorge D. Machicado · 1 shared paper, 2025 · strength 0.28
  8. Antonio Facciorusso · 1 shared paper, 2025 · strength 0.28
  9. Pujitha Kudaravalli · 1 shared paper, 2025 · strength 0.28
  10. Maria Cristina Conti Bellocchi · 1 shared paper, 2023 · strength 0.24
  11. Riccardo De Robertis · 2 shared papers, 2018–2024 · strength 0.23
  12. Francesca Lupo · 1 shared paper, 2025 · strength 0.17
  13. Pasquina Marzola · 1 shared paper, 2025 · strength 0.17
  14. Vincenzo Bronte · 1 shared paper, 2025 · strength 0.17
  15. Vincenzo Corbo · 1 shared paper, 2025 · strength 0.17
  16. Antonio Agostini · 1 shared paper, 2025 · strength 0.17
  17. Francesco De Sanctis · 1 shared paper, 2025 · strength 0.17
  18. Chiara Musiu · 1 shared paper, 2025 · strength 0.17
  19. Geny Piro · 1 shared paper, 2025 · strength 0.17
  20. Gabriella Lionetto · 1 shared paper, 2025 · strength 0.17
  21. Giampaolo Tortora · 1 shared paper, 2025 · strength 0.17
  22. Carmine Carbone · 1 shared paper, 2025 · strength 0.17
  23. Matteo De Pastena · 2 shared papers, 2018–2019 · strength 0.17
  24. Alberto Larghi · 1 shared paper, 2019 · strength 0.16
  25. Mihai Rimbaș · 1 shared paper, 2019 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.